JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
William R. Burfeind, Jr.
Betty C. Tong
Eric M. Toloza
Thomas A. D'Amico
David H. Harpole, Jr.
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burfeind, W. R.
Right arrow Articles by Harpole, D. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Burfeind, W. R., Jr.
Right arrow Articles by Harpole, D. H., Jr.
Related Collections
Right arrow Lung - cancer

J Thorac Cardiovasc Surg 2008;136:597-604
© 2008 The American Association for Thoracic Surgery


General Thoracic Surgery

Quality of life outcomes are equivalent after lobectomy in the elderly

William R. Burfeind, Jr., MDa,*, Betty C. Tong, MDb, Erin O'Branski, PA-Cb, James E. Herndon, PhDc, Eric M. Toloza, MD, PhDb, Thomas A. D'Amico, MDb, Linda H. Harpole, MDd, David H. Harpole, Jr., MDb

a Thoracic Surgery, St Luke's Health Network, Bethlehem, Pennsylvania
b Division of Thoracic Surgery, Duke University Medical Center, Durham, North Carolina
c Cancer Statistical Center, Duke University, Durham, North Carolina
d GlaxoSmithKline, Research Triangle Park, North Carolina

Received for publication May 15, 2007; revisions received October 17, 2007; accepted for publication February 19, 2008.

* Address for reprints: William R. Burfeind Jr, MD, 701 Ostrum Street, Suite 201, Bethlehem, PA 18015. (Email: burfeiw{at}slhn.org).


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
Objective: Prospective analyses of quality of life in elderly patients after lobectomy are limited, yet surgeons often recommend suboptimal therapy to these patients on the basis of the belief that lobectomy is poorly tolerated. Surgical decision making in elderly patients with lung cancer is better informed when the benefits to survival and quality of life after lobectomy are understood.

Methods: By using a validated quality of life instrument, 422 patients were prospectively assessed preoperatively and 3, 6, and 12 months after lobectomy. Outcomes were analyzed with respect to age (group 1: <70 years and group 2: ≥70 years). The outcome domains of physical functioning, role functioning, emotional functioning, cognitive functioning, social functioning, global health, and pain in the chest were analyzed using a mixed model. The trend in quality of life was determined according to age. The Kaplan–Meier method was used for analysis of overall survival.

Results: The mean age was 60.1 years in group 1 (N = 256) and 74.7 years in group 2 (N = 166). Baseline demographics and quality of life were similar except that group 2 had better emotional functioning scores and worse pain in the chest scores. Postoperatively, both groups demonstrated significant decreases in quality of life at 3 months. However, at 6 and 12 months, all domains had returned to baseline except physical functioning, which remained below baseline in group 2. Emotional functioning improved postoperatively for both groups. Overall survival at 5 years was not different between groups.

Conclusion: By using a validated quality of life assessment tool with measurements at baseline and serially after resection in a large patient population, this analysis quantifies the degree of impairment of quality of life after lobectomy and documents time to full recovery for both age groups.



Abbreviations and Acronyms EORTC QLQ = European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; NSCLC = non–small cell lung cancer; QOL = quality of life



    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
In patients with early-stage non–small cell lung cancer (NSCLC), lobectomy achieves the best long-term survival.1Go Yet, successful operations for stages I and II lung cancer are associated with a 5-year survival of only 40% to 70%.2Go Thus, treatment is often palliative rather than curative. Most studies published to date are concerned primarily with traditional outcomes, such as operative morbidity and mortality or long-term survival. The complex interplay among the treatment's benefits, risks, and the expectations held by patients with lung cancer serve to focus attention on the importance of health-related quality of life (QOL).

Information on QOL after operations for lung cancer surgery is sparse. Between 1994 and 2004, only 9 published articles were found that described QOL after lung cancer operations.3-11Go Of the 9 studies, only 3 included preoperative assessments, and although most used a validated QOL instrument, only 2 used a cancer-specific instrument.8,10Go Clearly, a prospective, longitudinal study that follows a large patient population and that uses a cancer-specific instrument is needed to more accurately portray QOL after lung cancer operations.

Lung cancer disproportionately affects the elderly, with a median age at diagnosis of 70 years.12Go Prospective analyses of QOL in elderly patients after lobectomy are absent, yet surgeons may recommend operations with less proven oncologic efficacy to these patients on the basis of the belief that lobectomy is poorly tolerated. Surgical decision making in elderly patients with lung cancer is better informed when the benefits of lobectomy to survival and QOL are understood.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
This is a retrospective review of prospectively collected data. The study was approved by the institutional review board at Duke University Medical Center.

Patients and Quality of Life Assessments
Patients with suspected lung cancer, who were seen in the Duke Thoracic Oncology Program, were asked to complete a QOL questionnaire preoperatively and then postoperatively at 3, 6, and 12 months. A trained clinical research assistant administered the questionnaire on a touch-screen computer, and attempts were made to administer the questionnaire before meeting with the clinician. Only patients who completed the baseline QOL assessment and at least 1 postoperative QOL assessment, and had undergone an anatomic lobectomy were included in the study. For purposes of analysis, patients in group 1 were defined as less than 70 years of age and patients in group 2 were defined as 70 years or older.

Quality of Life Measures
QOL was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30). The QLQ-C30 is a validated instrument for measuring QOL in patients with cancer and consists of 5 functional scales, 3 symptom scales, and a global health status/QOL scale (sample questions can be seen at http://groups.eortc.be/qol/downloads/modules/specimen_20qlq_c30.pdf).13Go In addition, 2 symptom scales for pain in the chest and pain in the arm/shoulder, as well as a dyspnea symptom scale, from the validated lung cancer module (QLQ-LC13), were used. Both questionnaires are designed for self-completion by the patient. For the functional scales (ie, those exploring physical, role, emotional, cognitive, and social functioning) and global health status, a higher value corresponds to a higher level of function or high QOL. Conversely, a higher score in a symptom scale corresponds to a higher level of symptoms or problems.

Statistical Considerations
The baseline characteristics of group 1 and group 2 were compared using the Fisher's exact test for dichotomous outcomes, and a 2-tailed t test was used for continuous variables. QOL scores collected from the EORTC QLC-C30 were linearly transformed to a scale of 0 to 100 in accordance with the EORTC guidelines.14Go The major objective of this study was to determine how QOL changed longitudinally and to compare differences between group 1 and group 2. This comparison was made by fitting a linear mixed model for repeated measures with restricted maximum likelihood estimation method for each EORTC functional scale, the global QOL scale, as well as 2 pain scales and the dyspnea scale (SAS PROC MIXED, SAS Institute Inc, Cary, NC). Effects modeled included the patient's age group, survey time (preoperatively, 3, 6, or 12 months), and interaction between age group and survey time. Of primary interest in these analyses was the interaction, a measure of whether the effect of time on outcomes was the same between the 2 groups.

Because 20% to 38% of data were missing, sensitivity analyses were conducted to examine the effect of missing data on inferences. The model was reanalyzed with data imputed to replace the missing data. A Monte Carlo Markov Chain approach to multiple imputations was used with SAS PROC MI. The correlation of the 4 assessments of each outcome, marital status, living situation, sex, stage, education, and video-assisted thoracic surgery use, were used in estimating 5 complete datasets or imputations. A mixed linear model (SAS PROC MIXED) was fit to each dataset with factors describing the effect of time, age group, and their interaction. The results for the interaction were combined across models using SAS PROC MIANALYZE.

The survival function was estimated using the Kaplan–Meier method. Overall survival was calculated from the date of surgery to the date of death from any cause or censored at June 1, 2006. Survival was expressed as a proportion, and survival curves were compared using the log-rank statistic. SAS version 9.1 (SAS Institute Inc) was used for all analyses.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
Patients
Between January 1, 1999, and September 25, 2005, 564 patients took an initial QOL survey and underwent lobectomy at Duke University Medical Center. A total of 142 patients (N = 82 group 1 and N = 60 group 2) took only 1 survey and were excluded from this analysis. Reasons for patients taking only 1 survey included death within 3 months of surgery (N = 8 group 1 and N = 12 group 2, P = .09), patients still within first 3 months of follow-up (N = 16 group 1 and N = 6 group 2, P = .16), and patients who were still alive but lost to follow-up (N = 58 group 1 and N = 42 group 2, P = 1.0).

A total of 422 patients completed at least 1 postoperative survey and were included in this study. Demographics from the eligible patients are listed in Table 1 . As indicated, the majority of patients were white and married, and had stage 1 or 2 NSCLC. The 2 groups were well balanced with respect to patient characteristics.


View this table:
[in this window]
[in a new window]

 
Table 1 Baseline demographics
 
Quality of Life at Baseline
In compliance with entry criteria, all patients had preoperative QOL assessments. Table 2 summarizes the baseline QOL for each functional scale and symptom scale. The 2 groups were similar except that group 2 had higher emotional functioning and less pain in the chest at baseline.


View this table:
[in this window]
[in a new window]

 
Table 2 Baseline quality of life, mean scores
 
Quality of Life Completion
All patients were asked to complete the QOL questionnaire at regularly scheduled follow-up appointments starting 3 months postoperatively. Subsequent completion rates varied between 62% and 80% for both groups (Table 3 ). Completion rates for each survey time point were similar between groups except at the 3-month survey, where 72% of group 1 and 62% of group 2 completed surveys (P = .39). The most common reason for not completing a survey was failure to show in the clinic. Because of the retrospective nature of the study, it was impossible to capture the patient's specific reason for failing to show in the clinic at the proper survey time (eg, too sick, feeling too well, receiving cancer follow-up elsewhere).


View this table:
[in this window]
[in a new window]

 
Table 3 Quality of Life Questionnaire compliance
 
Longitudinal Quality of Life
Subsequent QOL mean scores are listed in Table 4 . Both groups 1 and 2 experienced significant reductions in physical functioning, role functioning, social functioning, and global QOL domains at the 3-month survey. Similarly, both groups had increased pain in their chests and arm, as well as increased dyspnea, at 3 months. By the 6-month survey, the QOL domains had returned to baseline for both groups. All domains except physical functioning remained not significantly different from baseline at the 12-month survey (Figure 1 ). Physical functioning decreased below baseline in group 2 at the 12-month survey. Emotional functioning did not change at the 3-month survey but then significantly increased at both the 6 and 12-month surveys for both groups. Cognitive functioning did not differ from baseline at any of the subsequent survey times. The symptom scales for pain returned to preoperative values by 6 months and remained similar to baseline at 12 months. The dyspnea symptom scale recovered some but remained above baseline for the 6 and 12-month surveys. The linear mixed model examining the overall effect of the interaction between survey time and group was not significant for any domain or symptom scale. This suggests that although both groups experienced changes in QOL over the year, they did not differ from each other. The P values for the overall interaction were as follows: physical functioning = .08, role functioning = .33, emotional functioning = .20, cognitive functioning = .24, social functioning = .08, global QOL = .54, pain in chest = .98, pain in arm = .39, and dyspnea = .89. The sensitivity analysis with multiply imputed data sets confirmed that there was no evidence of a statistically significant interaction. The resulting P values were physical functioning = .36, role functioning = .65, emotional functioning = .40, cognitive functioning = .35, social functioning = .38, and global QOL = .85.


View this table:
[in this window]
[in a new window]

 
Table 4 Quality of life scores at each assessment point
 

Figure 1
View larger version (14K):
[in this window]
[in a new window]

 
Figure 1. QOL after lobectomy. Mean QOL domain scores plotted as a function of survey time.

 
Survival
Survival for the 2 groups is depicted in Figure 2 . Median follow-up for the whole cohort was 28.3 months. Median survival was calculated to be 73.1 months for group 1 and 56.7 months for group 2. There was no significant difference between survival curves by log-rank test (P = .72).


Figure 2
View larger version (16K):
[in this window]
[in a new window]

 
Figure 2. Overall survival via the Kaplan–Meier method. Survival was compared with the log-rank statistic.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
Health-related QOL is being increasingly recognized as an important issue in cancer care and research. Yet, information on QOL after lung cancer operations is limited. This study compared preoperative and postoperative QOL after lobectomy in 422 patients and specifically analyzed these changes with respect to age. A clinically validated, cancer-specific instrument was used to measure QOL in patients who underwent lobectomy predominantly for early-stage NSCLC. To our knowledge, this study represents the largest prospective, longitudinal, evaluation of QOL in patients undergoing operations for lung cancer to date.

The multidimensional nature of the QOL assessment raises some important issues of interpretation. Multiplicity of comparisons and interdependency of responses at successive times make it necessary to focus on the whole pattern of results. The exclusive use of patients with complete data provides unbiased, albeit inefficient, results, if the data that are missing occurs completely at random. Alternatively, it provides biased results, if data that are missing occurs not completely at random (the more common form of missingness). In this study we used a linear mixed-effect model to analyze all available data and to reconcile the fact that intrasubject QOL measurements are not independent (repeated measures).15Go On the basis of this analysis, both groups demonstrated significant reductions in physical, role, social, and global QOL domains, as well as increased pain involving the chest and arm/shoulder, and increased dyspnea at 3 months postoperatively. All parameters, except dyspnea, had recovered to baseline values by 6 months. Both groups demonstrated a similar decrement in QOL with a parallel return to baseline. The one notable exception was in the domain of physical functioning, which had returned to baseline by 6 months and decreased below its preoperative value in patients 70 years or older by 12 months. It is unclear whether physical functioning remained reset at this lower level or continued to deteriorate over time in these patients.

Patients aged 70 years or more had less impairment in emotional functioning preoperatively. This domain remained at its baseline value in both groups through the first 3 months after operation, but then demonstrated a significant increase by 6 months. This trend persisted through the end of the study. This reduction in emotional functioning preoperatively may be explained in part by the psychologic impact related to the recent cancer diagnosis. Not surprisingly, worsened emotional functioning seems to affect younger patients more than the older patients. In a similar pattern, older patients seem to perceive pain as being less severe both at baseline and postoperatively when compared with younger patients.

The observation that QOL decreases over the first 3 to 6 months postoperatively and then returns to its preoperative level has been reported by others. Dales and colleagues9Go reported on 117 patients who underwent thoracotomy for presumed lung cancer (NSCLC in 91, other pathology in 26). QOL was measured with the Sickness Impact Profile (SIP) and Spitzer QL-Index preoperatively and at 1, 3, 6, and 9 months postoperatively. Dales and colleagues found that QOL and dyspnea significantly worsened at 1 and 3 months postoperatively but returned to baseline at 6 and 9 months. Zieren and colleagues10Go reported similar findings using the Spitzer QL-Index and an earlier version of the EORTC QLQ (QLQ-CLC36). They examined 2 cohorts of patients who had undergone curative operations for lung cancer; 1 cohort completed a single QOL survey 12 months postoperatively (N = 52) and another was surveyed preoperatively and then again at discharge (median 11 days) and 3, 6, 9, and 12 months postoperatively (N = 20). In the latter cohort, patients demonstrated significant decreases in physical, role, and global domains of QOL, and increases in disease symptoms, such as dyspnea, at discharge. These differences, however, had disappeared at the 3-month survey.

Handy and colleagues6Go reported on 139 patients undergoing lung resections who were evaluated with the short-form health survey [36 items] and the Powers' QOL index before operation and then again at 6 months after operation. Preoperative QOL in patients undergoing operation for lung cancer was significantly worse than in healthy controls. Handy and colleagues found that at 6 months, subscales for physical functioning, role-physical, bodily pain, and mental health on the short-form health survey [36 items] were significantly worse than baseline. Because the data collected were truncated at 6 months, however, it is uncertain whether these findings persisted at 12 months. In addition, Handy and colleagues found that emotional functioning, although not significantly worsened, failed to improve with time. An unanswered question is whether the difference in their findings compared with those of the present study can be attributed to a different patient population or differences in QOL instruments.

Compliance with the QOL assessment, defined as the number of assessments actually completed as a proportion of those expected, ranged from 62% to 80%.16Go The most commonly missed survey time point was the 3-month survey with 28% of group 1 and 38% of group 2 missing this time point. Missing data were rarely the result of patient refusal or neglect, because a trained clinical research nurse guided each patient through their surveys. A more common reason was a failure of the patient to return for clinic follow-up within the prescribed time frame. Compliance with the QOL assessment is important because the failure to return for clinic follow-up may be influenced by the patient's QOL at that particular time point.17Go Because of the retrospective nature of this study, it is not possible to determine whether a patient missed the assessment because of postoperative disability, with associated poor QOL, or because he or she was recovering exceptionally well and chose to skip a clinic visit. Moreover, because of our large referral area, some patients may have chosen to receive part of their cancer care with their local area physician. Certainly, the larger percentage of group 2 patients who missed their 3-month survey could introduce significant bias if these patients did so because of increased postoperative disability.

Missing data are common in QOL studies, and they are usually not missing completely at random.18Go Thus, to account for missing data, appropriate statistical modeling (linear mixed model) was used. Sensitivity analysis was performed by replacing the missing data with multiply imputed values that were generated from individual baseline characteristics and previous QOL values.19Go Furthermore, the same linear mixed model was used to analyze each of the 5 imputed datasets, and SAS PROC MIANALYZE was applied to combine the results across models. Although it is impossible for any model to completely remove all possible bias, the findings from this analysis confirmed the original results; no difference in QOL was observed between groups.

Overall survival for the 2 groups was not different, whereas median survival time for the 2 groups appeared different because of a separation in survival curves at approximately 60 months. The median survival was 73 months for group 1 and 56.7 months for group 2.

The most important limitation to the generalizability of this study's findings is the selection bias inherent in its retrospective design. The study cohort represented patients who were motivated and willing to complete QOL surveys, preoperatively and postoperatively. This study delineated the time course of change in QOL after lobectomy, but its conclusions obviously do not help a surgeon choose which particular elderly patient will survive a major lung cancer operation. Indeed, although not statistically significant, more patients in group 2 died within 90 days of completing the preoperative survey than in group 1 (12 patients in group 2 vs 8 patients in group 1). Another limitation to this study's generalizability is the relatively high percentage of women who were enrolled (55.9% in group 1 and 47.6% in group 2). This proportion is slightly higher than the general pool of patients with lung cancer and may indicate that women generally are more willing to complete QOL surveys.

To summarize the main findings, this study delineates the magnitude of the change in QOL experienced by younger and older patients undergoing anatomic lobectomy and shows that they have similar decrements to 3 months. This study also documents that the time course to recovery of QOL in both groups is generally less than 6 months.


    Conclusions
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 
This study examined the longitudinal QOL in a large cohort of patients with lung cancer undergoing lobectomy, using a clinically validated, cancer-specific instrument. Postoperative QOL was reduced transiently and to a similar degree in patients aged less than 70 years and in patients aged 70 years or more. Further, the 5-year survival between groups was equivalent. These data support the use of lobectomy in selected elderly patients with lung cancer.


    Footnotes
 
Presented at the American Association for Thoracic Surgery, Washington, D.C., May 8th, 2007.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusions
 References
 

  1. Ginsberg RJ. Rubenstein LV for the LCSG. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-623.[Abstract/Free Full Text]
  2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.[Medline]
  3. Mangione CM, Goldman L, Orav EJ, et al. Health related quality of life after elective surgery: measurement of longitudinal changes. J Gen Intern Med 1997;12:686-697.[Medline]
  4. Myrdal G, Valtysdottir S, Lambe M, Stahle E. Quality of life following lung cancer surgery. Thorax 2003;58:194-197.[Abstract/Free Full Text]
  5. Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long term survivors of non-small cell lung cancer. J Clin Oncol 2002;20:2920-2929.[Abstract/Free Full Text]
  6. Handy Jr. JR, Asaph JW, Skokan L, et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 2002;122:21-30.[Medline]
  7. Welcker K, Marian P, Thetter O, Siebeck M. Cost and quality of life in thoracic surgery-a health economic analysis in a German center. Thorac Cardiovasc Surg 2003;51:260-266.[Medline]
  8. Li WW, Lee TW, Lam SS, et al. Quality of life following lung cancer resection: video-assisted thoracic surgery vs thoracotomy. Chest 2002;122:584-586.[Medline]
  9. Dales RE, Belanger R, Shamji FM, Leech J, Crepeau A, Sachs HJ. Quality of life following thoracotomy for lung cancer. J Clin Epidemiol 1994;47:1443-1449.[Medline]
  10. Zieren HU, Muller JM, Hamberger U, Pichlmaier H. Quality of life after surgical therapy of bronchogenic carcinoma. Eur J Cardiothorac Surg 1996;10:233-237.[Abstract/Free Full Text]
  11. Sugiura H, Morikawa T, Kaji M, Sasamura Y, Kondo S, Katoh H. Long-term benefits for the quality of life after video-assisted thoracoscopic lobectomy in patients with lung cancer. Surg Laparosc Endosc Percutan Tech 1999;9:403-408.[Medline]
  12. Ries LAG, Harkins D, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006. Accessed April 2007.
  13. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.[Abstract/Free Full Text]
  14. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group The EORTC QLQ-C30 Scoring Manual. 3rd edition. Brussels: European Organization for Research and Treatment of Cancer; 2001.
  15. Fairclough DL, Peterson HF, Cella D, Bonomi P. Comparisons of several model-based methods for analyzing incomplete quality of life in cancer clinical trials. Stat Med 1998;17:781-796.[Medline]
  16. Machin D, Weeden S. Suggestions for the presentation of quality of life data from clinical trials. Stat Med 1998;17:711-724.[Medline]
  17. Bernhard J, Cella DF, Coates AS, et al. Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med 1998;17:517-532.[Medline]
  18. Rubin DB. Inferences and missing data. Biometrika 1976;63:581-590.[Abstract/Free Full Text]
  19. Engels JM, Diehr P. Imputation of missing longitudinal data: a comparison of methods. J Clin Epidemiol 2003;56:968-976.[Medline]



This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
A. Moller and U. Sartipy
Long-term health-related quality of life following surgery for lung cancer
Eur J Cardiothorac Surg, February 1, 2012; 41(2): 362 - 367.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
K. Amer, A.-Z. Khan, H. Vohra, and R. Saad
Is it safe to include octogenarians at the start of a video-assisted thoracic surgery lobectomy programme?
Eur J Cardiothorac Surg, February 1, 2012; 41(2): 346 - 352.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
A. Chambers, T. Routledge, J. Pilling, and M. Scarci
In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?
Interact CardioVasc Thorac Surg, June 1, 2010; 10(6): 1015 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
H. Endoh, S. Tanaka, T. Yajima, T. Ito, K. Tajima, A. Mogi, Y. Shitara, and H. Kuwano
Pulmonary function after pulmonary resection by posterior thoracotomy, anterior thoracotomy or video-assisted surgery
Eur J Cardiothorac Surg, May 1, 2010; 37(5): 1209 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
C. Pompili, A. Brunelli, M. Refai, F. Xiume, and A. Sabbatini
Does chronic obstructive pulmonary disease affect postoperative quality of life in patients undergoing lobectomy for lung cancer? A case-matched study
Eur J Cardiothorac Surg, March 1, 2010; 37(3): 525 - 530.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
U. Sartipy
Prospective population-based study comparing quality of life after pneumonectomy and lobectomy
Eur J Cardiothorac Surg, December 1, 2009; 36(6): 1069 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. F. Berry, J. Hanna, B. C. Tong, W. R. Burfeind Jr, D. H. Harpole, T. A. D'Amico, and M. W. Onaitis
Risk Factors for Morbidity After Lobectomy for Lung Cancer in Elderly Patients
Ann. Thorac. Surg., October 1, 2009; 88(4): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. R. Villamizar, M. D. Darrabie, W. R. Burfeind, R. P. Petersen, M. W. Onaitis, E. Toloza, D. H. Harpole, and T. A. D'Amico
Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy.
J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al.
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Eur. Respir. J., July 1, 2009; 34(1): 17 - 41.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. K. Ferguson, C. M. Parma, A. D. Celauro, and W. T. Vigneswaran
Quality of Life and Mood in Older Patients After Major Lung Resection
Ann. Thorac. Surg., April 1, 2009; 87(4): 1007 - 1013.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
William R. Burfeind, Jr.
Betty C. Tong
Eric M. Toloza
Thomas A. D'Amico
David H. Harpole, Jr.
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burfeind, W. R.
Right arrow Articles by Harpole, D. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Burfeind, W. R., Jr.
Right arrow Articles by Harpole, D. H., Jr.
Related Collections
Right arrow Lung - cancer


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS